Q4 & FY22 Highlights

Financial Highlights All figures in Rs. Crore Revenue Normalised EBITDA* Normalised PBT** Normalised PAT** Total & Non Covid 493.8 369.1 2,087.4 600.4 394.4 296.5 1691.3 462.6 1,581.3 1257.1 會 +32% +34.5% Margin Margin Margin 24.9% Margin 23.7% 29.3% 28.8% Margin 18.7% Margin 17.7% FY21 FY22 FY21 FY22 FY21 FY22 FY21 FY22 Normalised EBITDA excl. RSU, CSR **Normalised PBT & PAT excl. notional depreciation on consolidation of Suburban Note: Results includes Suburban financials wef 12th Nov 21. On transition from IGAAP to IND AS, revenue adjusted as per IND AS 115. Financial results of the Company are best monitored on a year to date basis, as there is a certain level of seasonality in business and specific quarter performance may be influenced by certain occurrences in that quarter 30 Dr Lal PathLabs

View entire presentation